🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

White Willow (Salix alba) bark extract
200 mg
📊 Market median: 380.0mg (120 products) 📚 8 studies — no high-quality reviews
This product: 200mg
White Willow
100 mg

Other Ingredients

Rice Flour Cellulose Calcium Silicate

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (67% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, take one (1) capsule twice a day with food or water.

⚠️ Warnings & Precautions

Warning: Keep out of reach of children.

Do not use if safety seal is damaged or missing.

If you are pregnant, nursing, taking aspirin or other blood-thinning agents consult with your healthcare practitioner before use.

Discontinue 2 weeks prior to surgery, or if upset stomach occurs.

🧪 Formulation Notes

Salix alba/Tanacetum parthenium

Vegan

Additional Information

Store in a cool, dry place.

For product information, call (800) 439-2324.

Product Details

UPC / SKU 0 83000 16445 3
DSLD Entry Date 2022-04-11
Product Type Botanical
Form Capsule
DSLD ID 264129
Data Updated 2026-04-11

Research Evidence

10 Research Sources
48 Avg Quality Score
4 Systematic Review
4 Rct
1 Meta Analysis
1 Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985
View all evidence for Feverfew →

Compare Similar Products

View all Feverfew products →